Pancreatic cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients who received pathological diagnosis of pancreatic cancer including ductal adenocarcinoma or adenosquamous carcinoma (2) Patients categorized as borderline resectable before the initiation of neoadjuvant treatment (3) Patients undergoing curative-intent resection after neoadjuvant therapy
Exclusion criteria
Exclusion criteria: (1) Patients in whom final pathological diagnosis is not pancreatic cancer including ductal adenocarcinoma or adenosquamous carcinoma (2) Patients who had locally-advanced or unresectable factors on preoperative imaging findings (3) Patients who had locally-advanced or unresectable factors in intra-operative findings (4) Patients who died of postoperative complications (5) Patients judged ineligible for the study by the research representative
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To identify predictive factors for early recurrence in patients with borderline resectable pancreatic cancer undergoing curative resection after neoadjuvant therapy | — |
Countries
Japan
Contacts
Graduate School of Medicine, Kyoto University Division of Hepato-Biliary-Pancreatic Surgery and Transplantion, Department of Surgery